Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 09:24:33 GMT 2023
by
admin
on
Sat Dec 16 09:24:33 GMT 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | HUMAN |
| Source Materials Parent | |
| Part | PLASMA |
| Fraction Material Type | PROTEIN |
| Fraction Name | IGG |
| Record UNII |
SX5Y4A7UBI
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EU-Orphan Drug |
EU/3/05/319
Created by
admin on Sat Dec 16 09:24:33 GMT 2023 , Edited by admin on Sat Dec 16 09:24:33 GMT 2023
|
||
|
FDA ORPHAN DRUG |
178703
Created by
admin on Sat Dec 16 09:24:33 GMT 2023 , Edited by admin on Sat Dec 16 09:24:33 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SX5Y4A7UBI
Created by
admin on Sat Dec 16 09:24:33 GMT 2023 , Edited by admin on Sat Dec 16 09:24:33 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| TARGETED ANTIGEN | IMMUNOLOGICAL |
|
STAPHYLOCOCCUS AUREUS | O478WX4004 |